Inactivated emulsion marker strain-based vaccine against Aujeszky’s disease

Description

The vaccine is produced based on BK strain of inactivated marker (gE) Aujeszky’s disease virus grown in continuous cell line and emulsified with oil adjuvant. In appearance the vaccine is white or white-pink slightly viscous emulsion. During storage slight mineral oil separation at the top of the bottle and emulsion consolidation at the bottom of the bottle are admissible.

The vaccine becomes homogeneous again after shaking.

Indications

The vaccine is intended for the preventive immunization of swine against Aujeszky’s disease on farms infected with and at risk of the said disease. The use of this vaccine allows to distinguish between animals having vaccine-induced antibodies against vaccine marker strain and animals having post infection antibodies against field AD virus; this vaccine can be used in AD control and eradication programs. Vaccinated pigs have no antibodies against glycoprotein gE. Antibodies against glycoprotein gE are detected in blood sera of animals infected by the field AD virus.

Route of administration

To vaccinate pigs 2 cm3 of the vaccine should be administered intramuscularly in the middle third of the neck. Piglets under 2 months of age should be vaccinated at a dose of 1.0 cmâ. Only clinically healthy animals should be vaccinated. Sows and replacement gilts should be vaccinated twice with a 3-6 week interval not later than one month before farrowing. Then previously immunized sows should be revaccinated once every 4 months, but not later than one month before farrowing. Breeding boars should be vaccinated twice with a 3-6 week interval every 6 months. Piglets from vaccinated sows should be vaccinated against Aujeszky’s disease from the age of 8 weeks using live or inactivated marker gE-deleted vaccines in compliance with the vaccine package leaflet. Piglets from non-vaccinated sows and having no colostrum antibodies against Aujeszky’s disease virus may be vaccinated since birth, twice, with a 2-4 week interval.

Immunity

The vaccine induces immune response against Aujeszky’s disease in 21 days after double administration. The immunity duration is not less than 6 months.

Storage conditions

The vaccine shelf life is 12 months from the date of its production provided that it is stored in dry dark place at 2 – 8 °C. Freezing of the vaccine is not allowed.

FGBI “ARRIAH” produces bivalent associated vaccines against Aujeszky’s disease and porcine reproductive and respiratory syndrome, and against Aujeszky’s disease and parvovirus disease and it produces trivalent associated vaccine against porcine reproductive and respiratory syndrome, parvovirus and Aujeszky’s disease. These types of vaccines are used in farms infected with and at risk of the said diseases. The vaccines should be administered in compliance with the vaccine package leaflet.

Disease: 
Aujeszky’s disease
Strain/ serotype: 
BK
Appearance: 
Inactivated emulsion
Filling/ dosage: 
10, 50, 100 and 200 cm 3 bottles
Measurement unit: 
one thousand doses
Instructions: 
Certificates: